Anlon Healthcare Limited has executed two Share Swap Agreements on August 08, 2026, pursuant to Regulation 30 of SEBI Listing Regulations.

Acquisition Details - Apiqo Organics Private Limited (AOPL)

  • Target Company: Apiqo Organics Private Limited (CIN: U21001GJ2025PTC169863)
  • Incorporation Date: December 1, 2025 (converted from partnership firm)
  • Business: Manufacturing pharmaceutical intermediate, industrial and fine chemicals, and inorganic chemicals
  • Turnover: ₹7,254.11 lakh (FY 2025-26), ₹4,554.36 lakh (as of June 30, 2026)
  • Historical Turnover: ₹1,711.10 lakh (2023-24), ₹977.78 lakh (2024-25), ₹7,254.11 lakh (2025-26)
  • Industry: Pharmaceuticals
  • Related Party Transaction: Yes, as promoters and some directors are common in both entities
  • Transaction Basis: Arm's length basis
  • Consideration: Approximately ₹1,165,179,600 via share swap (no cash consideration)
  • Share Acquisition: Up to 45,16,200 equity shares at ₹258 each
  • Regulatory Approvals: Stock exchange listing and trading approval required
  • Completion Timeline: Within 90 days from signing or mutually agreed timeline

Acquisition Details - Bizotic Lifescience Private Limited (BLPL)

  • Target Company: Bizotic Lifescience Private Limited
  • Incorporation Date: April 17, 2015
  • Business: Manufacturing, supplying and exporting pharmaceutical drugs and intermediates, industrial and fine chemicals, active pharmaceutical ingredients (API), contract research and manufacturing services
  • Turnover: ₹3,126.64 lakh (FY 2025-26), ₹1,152.78 lakh (as of June 30, 2026)
  • Historical Turnover: ₹380.39 lakh (2023-24), ₹3,038.20 lakh (2024-25), ₹3,126.64 lakh (2025-26)
  • Industry: Pharmaceuticals
  • Related Party Transaction: Yes, as promoters and some directors are common in both entities
  • Transaction Basis: Arm's length basis
  • Consideration: Approximately ₹367,840,000 via share swap (no cash consideration)
  • Share Acquisition: Up to 22,99,000 equity shares at ₹160 each
  • Regulatory Approvals: Stock exchange listing and trading approval required
  • Completion Timeline: Within 90 days from signing or mutually agreed timeline

Preferential Issue Details

  • Type of Securities: Equity shares
  • Type of Issuance: Preferential allotment for consideration other than cash (share swap)
  • Total Shares Proposed: Up to 8,58,83,617 equity shares
  • Share Exchange Ratio: 1:14.45 for AOPL, 1:8.96 for BLPL
  • Fractional Entitlement: Rounded off to nearest whole equity share

Investor Details

  • AOPL Investors: Up to 160 shareholders including Punitkumar Rameshbhai Rasadia, Meet Atulkumar Vachhani, and 158 other shareholders
  • BLPL Investors: Up to 173 shareholders including Punitkumar Rameshbhai Rasadia, Meet Atulkumar Vachhani, and 171 other shareholders

Shareholding Impact (Assuming Full Acceptance)

Preferential Holding:

  • Punitkumar Rameshbhai Rasadia: 18,59,20,000 shares
  • Meet Atulkumar Vachhani: 9,40,80,000 shares

Post-allotment Holding:

  • Punitkumar Rameshbhai Rasadia: 20,43,39,402 shares
  • Meet Atulkumar Vachhani: 10,34,31,099 shares

Strategic Objectives

The acquisitions are made to strengthen the supply of critical materials, achieve strategic synergies, enhance operational efficiency, improve long-term competitiveness, and enhance shareholder value.